About Kuros Biosciences, Inc.
OUR PURPOSE Kuros Biosciences is on a mission to discover, develop and deliver innovative biologic technologies. OUR CREDENTIALS Kuros is a Swiss-headquartered biotech company, listed on the SIX Swiss Stock Exchange since 2016 (under symbol KURN). With additional operations in the Netherlands and the USA, we continue to grow our global team. To deliver the ideal bone graft, you need the highest quality and quantity of scientific evidence behind it. We believe that this is a key differentiator for Kuros, given the urgent need to advance bone healing. โข Listing on the ๐ฆ๐๐ซ ๐ฆ๐๐ถ๐๐ ๐๐ ๐ฐ๐ต๐ฎ๐ป๐ด๐ฒ under the symbol KURN since 2016 โข A commercial & research footprint that spans >๐ฎ๐ฌ ๐บ๐ฎ๐ฟ๐ธ๐ฒ๐๐ โข Dozens of ๐ฐ๐น๐ถ๐ป๐ถ๐ฐ๐ฎ๐น ๐ฎ๐ป๐ฑ ๐๐ฐ๐ถ๐ฒ๐ป๐๐ถ๐ณ๐ถ๐ฐ ๐ฒ๐ ๐ฝ๐ฒ๐ฟ๐ ๐ฎ๐ฑ๐๐ถ๐๐ฒ๐ฟ๐ โข >๐ฎ๐ฑ orthobiologics-related ๐ฝ๐ฎ๐๐ฒ๐ป๐๐ โข >๐ฐ๐ฌ๐ฌ ๐ฝ๐ฎ๐๐ถ๐ฒ๐ป๐๐ ๐ฒ๐๐ฎ๐น๐๐ฎ๐๐ฒ๐ฑ in Level I, randomized controlled clinical trials โข >๐ฎ๐ฌ well-controlled ๐๐ฒ๐๐ฒ๐น ๐-๐๐ฉ ๐ฐ๐น๐ถ๐ป๐ถ๐ฐ๐ฎ๐น ๐๐ฟ๐ถ๐ฎ๐น๐ ๐ถ๐ป๐ถ๐๐ถ๐ฎ๐๐ฒ๐ฑ, including 6 that are completeยน โข Published Level I evidence published in ๐๐๐๐๐ CONTACT KUROS TO FIND OUT MORE >>>>
